An ELISA for measuring tumour necrosis factor α in rat plasma

European Cytokine Network

Volumn 8, Issue 1, 1997, Pages 97-102

  Campbell, Gordon R ^a   Magee, Damian ^a   Kennedy, Andrew ^a   Rowlands, Brian J ^a   Halliday, M Isla ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Cytokines; Immunoassay; Peritonitis; Rat TNF

Indexed keywords

CROSS REACTING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; PROTEIN DETERMINATION; RAT; TISSUE CULTURE;

ANIMALIA; MURINAE;

EID: 0030889170     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Nathan C, Sporn M. 1991. Cytokines in context. J. Cell Biology. 113 :981.
2. Tracy K J. 1991. TNF (cachectin) in the biology of septic shock syndrome. Circulatory Shock. 35:123.
3. Beutler B, Cerami A. 1988. Tumor necrosis, Cachexia, Shock and inflammation: a common mediator. Ann. Rev. Biochem. 57:505.
4. Estler H, Grewe M, Gaussling R, Pavlovic M, Decker K. 1992. TNF-α. Transcription in rat kupffer cells and in vitro post translational processing based on a PCR derived cDNA. Biol. Chem. 373:271.
5. Corti A, Fassina G, Marcucci F, Barbanti E, Cassani G. 1992. Oligomeric TNF slowly converts into inactive forms at bioactive levels. J. Biochem. 284:905.
6. Espevik T, Nissen-Meyer J. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/TNF from human moncytes. J. Immunological Methods. 95:99.
7. Endelberg I, Moller A, Schoen G J M, van der Linden C J, Buurman W A. 1991. Evaluation of the measurement of Human TNF in plasma by ELISA. Lymphokine CytokineRes. 10:69.
8. Silva A T, Applemelk B J, Buurman W A, Bayston B J, and Cohen J. 1990. Monoclonal antibody to endoloxin core protects mice from Escherichia coli sepsis by a mechanism independent of TNF and IL-6. J. Infect. Diseases. 162:454.
9. Von Asmuth E, Maessen J, and Vanderlinden C. 1990. TNF and IL-6 in a zymosan induced shock model. Scand J Immunol. 32:313.
10. Gifford G E, Lohmann-Matthes M L. 1986. Requirement for the continual presence of lipopolysaccharide for the production of TNF by thioglycollate-induced peritoneal macrophages. Br. J. Cancer. 38:135.
11. Eskandari M., Bolgos G, Miller C, Nguyen D, DeForge L, and Remick D. 1992. Anti-Tumor Necrosis Factor antibody therapy fails to prevent lethality after caecal ligation and puncture or endotoxemia. J. Immunol. 148: 2724.
12. Sheenan K, Ruddle N, Schreiber R. 1989. Generation and characterisation of hamster monoclonal antibodies that neutralise murine TNF. J Immmunology. 142:3884.
13. . Green S, Dobrjansky A, Chiasson M A. 1982. Murine Tumor Necrosis inducing factor: Purification and effects on Myelomonocytic Leukemia cells. J. Natl Cancer Inst. 68:997.
14. Haran N, Frensdorff B K, Barnard G. 1991. Tumor necrosis factor (TNF) binding protein: Interference in immunoassays of TNF. Kindney International. 40:1166.
15. Waage A, Espevik T, Lamvik J. 1986. Detection of tumour necrosis factor like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients. Scand. J. Immunol. 24:739.
16. Corti A, Fassina G, Marcucci F, Cassani G. 1992. Antigenic regions of tumour necrosis factor alpha and their topographic relationships with structural/functional domains. Molecular Immunology. 29: 471.
17. Flohe S, Heinrich P C, Schneider J, Wendel A, Flohe L. 1991. Time course of IL-6 and TNF release during endotoxin-induced endotoxin tolerance in rats. Biochemical Pharmacology. 41:1607.
18. Aderka D, Engelmann H, Hornik V, Skornick Y, Levo Y, Wallach D, Kushtai G. 1991. Increased serum levels of soluble receptors for TNF in cancer patients. Cancer Research. 51:5602.
19. Engelmann H, Novick D, Wallach D. 1990. Two TNF binding proteins purified from human urine. J. Biol Chem. 265:1531.
20. Aderka D, Engelmann H, Hornik V, Maor Y, Brakebusch C, Wallach D. 1992. Stabilization of the bioactivity of TNF by its soluble receptors. J. Exp. Med. 175:323.